var data={"title":"Alcoholic hepatitis: Clinical manifestations and diagnosis","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Alcoholic hepatitis: Clinical manifestations and diagnosis</div><dl id=\"topicContributors\"><dt><span> </span>Author:</dt><dd><a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/contributors\" class=\"contributor contributor_credentials\">Scott L Friedman, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/contributors\" class=\"contributor contributor_credentials\">Bruce A Runyon, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/contributors\" class=\"contributor contributor_credentials\">Kristen M Robson, MD, MBA, FACG</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Feb 13, 2018.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H418822015\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Excessive alcohol consumption is associated with a range of hepatic manifestations, including alcoholic fatty liver disease (with or without steatohepatitis), alcoholic hepatitis, and cirrhosis. The burden of alcoholic liver disease continues to grow [<a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/1,2\" class=\"abstract_t\">1,2</a>]. While asymptomatic steatohepatitis due to alcohol could be referred to as &quot;alcoholic hepatitis,&quot; the term is typically used to describe the acute onset of symptomatic hepatitis. The amount of alcohol intake that puts an individual at risk for alcoholic hepatitis is not known, but the majority of patients have a history of heavy alcohol use (more than 100 <span class=\"nowrap\">g/day)</span> for two or more decades (<a href=\"image.htm?imageKey=PC%2F68118\" class=\"graphic graphic_figure graphicRef68118 \">figure 1</a>) [<a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/3-5\" class=\"abstract_t\">3-5</a>]. Clinicians should not overlook the long-term need to encourage treatment for alcohol use disorder once the acute episode of alcoholic hepatitis has resolved [<a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/6\" class=\"abstract_t\">6</a>]. (See <a href=\"topic.htm?path=risky-drinking-and-alcohol-use-disorder-epidemiology-pathogenesis-clinical-manifestations-course-assessment-and-diagnosis\" class=\"medical medical_review\">&quot;Risky drinking and alcohol use disorder: Epidemiology, pathogenesis, clinical manifestations, course, assessment, and diagnosis&quot;</a>.)</p><p>This topic will review the clinical manifestations and diagnosis of alcoholic hepatitis. The management of alcoholic hepatitis, the pathogenesis of alcoholic liver disease, and the approach to patients with alcoholic fatty liver disease or alcoholic cirrhosis are discussed separately. (See <a href=\"topic.htm?path=management-and-prognosis-of-alcoholic-hepatitis\" class=\"medical medical_review\">&quot;Management and prognosis of alcoholic hepatitis&quot;</a> and <a href=\"topic.htm?path=pathogenesis-of-alcoholic-liver-disease\" class=\"medical medical_review\">&quot;Pathogenesis of alcoholic liver disease&quot;</a> and <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-alcoholic-fatty-liver-disease-and-alcoholic-cirrhosis\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of alcoholic fatty liver disease and alcoholic cirrhosis&quot;</a> and <a href=\"topic.htm?path=prognosis-and-management-of-alcoholic-fatty-liver-disease-and-alcoholic-cirrhosis\" class=\"medical medical_review\">&quot;Prognosis and management of alcoholic fatty liver disease and alcoholic cirrhosis&quot;</a>.)</p><p>The discussion that follows is generally consistent with society guidelines [<a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/7\" class=\"abstract_t\">7</a>]. (See <a href=\"#H4086322148\" class=\"local\">'Society guideline links'</a> below.)</p><p class=\"headingAnchor\" id=\"H66806154\"><span class=\"h1\">HISTORY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Patients with alcoholic hepatitis are often between 40 and 50 years of age, with most patients presenting before the age of 60 years [<a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/8\" class=\"abstract_t\">8</a>]. Patients with alcoholic hepatitis typically have a history of daily heavy alcohol use (&gt;100 <span class=\"nowrap\">g/day)</span> for more than 20 years (<a href=\"image.htm?imageKey=PC%2F68118\" class=\"graphic graphic_figure graphicRef68118 \">figure 1</a>) and in some cases, patients will have recently increased their alcohol intake in response to stressful life events [<a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/9\" class=\"abstract_t\">9</a>]. Patients often stop drinking as they become ill, so it is common for patients to have ceased alcohol intake several weeks prior to presentation [<a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/3,4,10,11\" class=\"abstract_t\">3,4,10,11</a>]. Drinking patterns may vary, however, and heavy drinking can be intermittent (ie, weekends only) or surreptitious, such that family members, friends, or coworkers may not recognize a pattern of problem drinking. In addition, alcoholic hepatitis can develop in patients with much shorter histories of heavy alcohol use [<a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/12\" class=\"abstract_t\">12</a>]. </p><p>Obtaining an accurate history of alcohol use from a patient with suspected alcoholic hepatitis may be difficult. Questioning the patient's family in private, after receiving permission from the patient to discuss his or her care with family members, may help elicit important information about the patient's alcohol use. It is also absolutely essential that health care providers take a careful alcohol history, supplemented by use of either the CAGE or AUDIT questionnaires to establish the likelihood of problem alcohol drinking or abuse (<a href=\"image.htm?imageKey=PC%2F54106\" class=\"graphic graphic_table graphicRef54106 \">table 1</a> and <a href=\"image.htm?imageKey=PC%2F74262\" class=\"graphic graphic_table graphicRef74262 \">table 2</a>). (See <a href=\"topic.htm?path=screening-for-unhealthy-use-of-alcohol-and-other-drugs-in-primary-care#H2788954\" class=\"medical medical_review\">&quot;Screening for unhealthy use of alcohol and other drugs in primary care&quot;, section on 'Unhealthy alcohol use'</a>.)</p><p class=\"headingAnchor\" id=\"H418822022\"><span class=\"h1\">CLINICAL MANIFESTATIONS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The characteristic clinical features of alcoholic hepatitis are jaundice, anorexia, fever, and tender hepatomegaly [<a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/13\" class=\"abstract_t\">13</a>]. Laboratory testing reveals moderately elevated transaminases (typically less than 300 int. <span class=\"nowrap\">unit/mL),</span> with an aspartate aminotransferase (AST) to alanine aminotransferase (ALT) ratio of two or greater. Patients may also present with right <span class=\"nowrap\">upper-quadrant/epigastric</span> pain, hepatic encephalopathy, and signs of malnutrition. </p><p class=\"headingAnchor\" id=\"H428430251\"><span class=\"h2\">Signs and symptoms</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Common signs and symptoms of alcoholic hepatitis include [<a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/14,15\" class=\"abstract_t\">14,15</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Jaundice that developed within three months prior to presentation.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Anorexia.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Fever. A fever should only be ascribed to alcoholic hepatitis once other sources are excluded, including spontaneous bacterial peritonitis, pneumonia, and urinary tract infections. (See <a href=\"topic.htm?path=management-and-prognosis-of-alcoholic-hepatitis#H234081674\" class=\"medical medical_review\">&quot;Management and prognosis of alcoholic hepatitis&quot;, section on 'General management for all patients'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Right <span class=\"nowrap\">upper-quadrant/epigastric</span> abdominal pain, which may be severe enough to mimic an acute abdomen.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Abdominal distension due to ascites.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Proximal muscle weakness due to muscle wasting.</p><p/><p>Patients with severe alcoholic hepatitis <span class=\"nowrap\">and/or</span> underlying cirrhosis may exhibit signs of hepatic encephalopathy (<a href=\"image.htm?imageKey=GAST%2F62922\" class=\"graphic graphic_table graphicRef62922 \">table 3</a>).</p><p class=\"headingAnchor\" id=\"H66805637\"><span class=\"h2\">Physical examination</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>On physical examination, patients typically have hepatomegaly, which often reflects the combined effects of fatty liver and swelling of hepatocytes due to cell injury-associated protein retention [<a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/16\" class=\"abstract_t\">16</a>]. The liver may be tender, but the presence of more diffuse abdominal pain is unusual and suggests other diagnoses, such as spontaneous bacterial peritonitis. A bruit heard over the liver is also a feature of severe alcoholic hepatitis and has been reported to occur in &gt;50 percent of patients [<a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/17\" class=\"abstract_t\">17</a>].</p><p>Patients often have ascites, which may be due to underlying cirrhosis with portal hypertension or transient portal venous obstruction from hepatic swelling. Paracentesis should be performed, under ultrasonic guidance if necessary, in all patients with confirmed ascites present on ultrasonography. The presence of stigmata of chronic liver disease (eg, spider angiomata, palmar erythema, gynecomastia) suggests advanced disease with underlying cirrhosis. (See <a href=\"topic.htm?path=cirrhosis-in-adults-etiologies-clinical-manifestations-and-diagnosis#H4\" class=\"medical medical_review\">&quot;Cirrhosis in adults: Etiologies, clinical manifestations, and diagnosis&quot;, section on 'Physical examination'</a>.)</p><p>In patients who are malnourished (common in those with severe alcoholic hepatitis), the physical examination may reveal proximal muscle wasting and decreased grip strength [<a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/18\" class=\"abstract_t\">18</a>]. </p><p class=\"headingAnchor\" id=\"H418826776\"><span class=\"h2\">Laboratory tests</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Patients with alcoholic hepatitis typically have:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Moderate elevations of the AST and ALT (typically less than 300 int. <span class=\"nowrap\">unit/L,</span> rarely higher than 500 int. <span class=\"nowrap\">unit/L)</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>An AST:ALT ratio &ge;2</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>An elevated serum bilirubin</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>An elevated gamma-glutamyl transferase (GGT)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>A leukocytosis with a predominance of neutrophils</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>An elevated international normalized ratio (INR)</p><p/><p>In addition, patients may have low serum albumin and prealbumin levels due to malnutrition and decreased synthesis in the setting of hepatic dysfunction. (See <a href=\"topic.htm?path=nutritional-assessment-in-chronic-liver-disease#H13\" class=\"medical medical_review\">&quot;Nutritional assessment in chronic liver disease&quot;, section on 'Plasma proteins'</a>.)</p><p class=\"headingAnchor\" id=\"H706893162\"><span class=\"h3\">Liver test abnormalities</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The serum AST and ALT are typically less than 300 int. <span class=\"nowrap\">unit/L</span> and are rarely higher than 500 int. <span class=\"nowrap\">unit/L,</span> except in patients with alcoholic foamy degeneration (a histologic variant of alcoholic hepatitis) [<a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/19,20\" class=\"abstract_t\">19,20</a>]. Higher transaminase concentrations should raise the suspicion of concurrent liver injury due to viral or ischemic hepatitis or <a href=\"topic.htm?path=acetaminophen-paracetamol-drug-information\" class=\"drug drug_general\">acetaminophen</a> use (which can be toxic even at therapeutic doses in patients who abuse alcohol) [<a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/21\" class=\"abstract_t\">21</a>]. The most common pattern of liver biochemical test abnormalities is a disproportionate elevation of serum AST compared with ALT. This ratio is usually two or greater in alcoholic hepatitis, a value that is rarely seen in other forms of liver disease [<a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/22-24\" class=\"abstract_t\">22-24</a>].<br/><br/>The lower elevation of the serum ALT relative to the AST has been ascribed to hepatic deficiency of pyridoxal 5'-phosphate in alcoholics, which is a cofactor for the enzymatic activity of ALT [<a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/25\" class=\"abstract_t\">25</a>]. According to this hypothesis, the altered ratio reflects a failure to appropriately increase the ALT, rather than a disproportionate elevation in AST. </p><p>Patients with alcoholic hepatitis typically have elevated serum bilirubin and GGT levels. In addition, the serum albumin and prealbumin may be low in patients who are malnourished or who have impaired synthetic function. In a therapeutic trial that included 174 patients with severe alcoholic hepatitis, mean bilirubin levels were 14 to 15 <span class=\"nowrap\">mg/dL</span> (238 to 260 <span class=\"nowrap\">micromol/L),</span> mean GGT levels were 223 to 309 int. <span class=\"nowrap\">unit/L,</span> and mean albumin levels were 2.4 to 2.5 <span class=\"nowrap\">g/dL</span> (24 to 25 <span class=\"nowrap\">g/L)</span> [<a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/26\" class=\"abstract_t\">26</a>]. Similarly, in a second trial, the median bilirubin level was 13 <span class=\"nowrap\">mg/dL</span> (222 <span class=\"nowrap\">micromol/L)</span> and the median albumin level was 2.4 <span class=\"nowrap\">g/dL</span> (24 <span class=\"nowrap\">g/L)</span> [<a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/27\" class=\"abstract_t\">27</a>]. </p><p class=\"headingAnchor\" id=\"H706893171\"><span class=\"h3\">Coagulation abnormalities</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Patients with moderate to severe alcoholic hepatitis typically have an elevated INR due to impaired production of coagulation factors by the inflamed liver. In a trial with 121 patients with severe alcoholic hepatitis, the median INR at baseline was 2.1 (range 1.3 to 6.4) [<a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/27\" class=\"abstract_t\">27</a>]. </p><p class=\"headingAnchor\" id=\"H706893178\"><span class=\"h3\">Hematologic abnormalities</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Hematologic abnormalities are common in moderate to severe alcoholic hepatitis. Moderate leukocytosis <span class=\"nowrap\">(&lt;20,000/microL)</span> is a frequent finding [<a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/10,26,28\" class=\"abstract_t\">10,26,28</a>]. In a study of 174 patients with alcoholic hepatitis, the mean white blood cell count was <span class=\"nowrap\">11,000/microL</span> [<a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/26\" class=\"abstract_t\">26</a>]. The majority of the white blood cells are neutrophils, which are also commonly seen in liver biopsies from patients with alcoholic hepatitis, suggesting these cells may play an important pathogenetic role in the hepatic injury. (See <a href=\"topic.htm?path=pathogenesis-of-alcoholic-liver-disease\" class=\"medical medical_review\">&quot;Pathogenesis of alcoholic liver disease&quot;</a>.)</p><p>Rarely, extremely high white blood cell counts (a leukemoid reaction) are seen and are associated with very high mortality rates. In a review of 10 cases of patients with alcoholic hepatitis and a leukemoid reaction, the white blood cell counts ranged from <span class=\"nowrap\">57,000/microL</span> to <span class=\"nowrap\">129,000/microL,</span> and only one patient survived [<a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/29\" class=\"abstract_t\">29</a>].</p><p>Macrocytosis suggests longstanding disease and may reflect poor nutritional status, cobalamin or folate deficiency, toxicity of alcohol, <span class=\"nowrap\">and/or</span> increased lipid deposition on red cell membranes. Similarly, thrombocytopenia can result from primary bone marrow hypoplasia (which can be due to alcohol and is usually brief) <span class=\"nowrap\">and/or</span> splenic sequestration due to portal hypertension and an enlarged spleen (&quot;hypersplenism&quot;). (See <a href=\"topic.htm?path=hematologic-complications-of-alcohol-use\" class=\"medical medical_review\">&quot;Hematologic complications of alcohol use&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H706893185\"><span class=\"h3\">Other laboratory test abnormalities</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Patients with severe alcoholic hepatitis may develop hepatorenal syndrome and thus may have an elevated creatinine. Acute phase reactants, such as serum ceruloplasmin, ferritin, and alpha 1-antitrypsin may be elevated in patients with severe alcoholic hepatitis [<a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/30-32\" class=\"abstract_t\">30-32</a>]. (See <a href=\"topic.htm?path=hepatorenal-syndrome#H4\" class=\"medical medical_review\">&quot;Hepatorenal syndrome&quot;, section on 'Clinical presentation'</a> and <a href=\"topic.htm?path=acute-phase-reactants\" class=\"medical medical_review\">&quot;Acute phase reactants&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H62755805\"><span class=\"h2\">Imaging tests</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Abdominal imaging (ultrasound, computed tomographic scan, magnetic resonance imaging) in patients with alcoholic hepatitis may suggest fatty change in the liver, evidence of underlying cirrhosis, or ascites. Transabdominal ultrasound may also reveal parallel tubular structures in the liver, thought to represent the dilated hepatic artery adjacent to a portal vein radical [<a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/33\" class=\"abstract_t\">33</a>]. Doppler flow studies of the hepatic artery may reveal an elevated peak systolic velocity or an increase in vessel diameter [<a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/34\" class=\"abstract_t\">34</a>]. Transient elastography may be useful in determining the likelihood of cirrhosis, although elevated liver stiffness in this setting may also reflect edema and inflammation [<a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/35\" class=\"abstract_t\">35</a>]. A reduction in liver stiffness may indicate abstinence or withdrawal from alcohol [<a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/36\" class=\"abstract_t\">36</a>]. (See <a href=\"topic.htm?path=noninvasive-assessment-of-hepatic-fibrosis-ultrasound-based-elastography\" class=\"medical medical_review\">&quot;Noninvasive assessment of hepatic fibrosis: Ultrasound-based elastography&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H418822029\"><span class=\"h1\">DIAGNOSIS</span></p><p class=\"headingAnchor\" id=\"H234080095\"><span class=\"h2\">Diagnostic approach</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Clinical and laboratory features are often adequate for establishing the diagnosis of alcoholic hepatitis in a patient with a long history of heavy alcohol use (typically &gt;100 <span class=\"nowrap\">g/day</span> for more than 20 years) (<a href=\"image.htm?imageKey=PC%2F68118\" class=\"graphic graphic_figure graphicRef68118 \">figure 1</a>), provided the patient does not have risk factors for other causes of acute hepatitis and testing for other common causes of hepatitis is negative. In such patients, we will make a clinical diagnosis of alcoholic hepatitis if the patient presents with jaundice, moderately elevated aminotransferases (typically &lt;300 int. <span class=\"nowrap\">unit/mL</span> and rarely higher than 500 int. <span class=\"nowrap\">unit/mL),</span> an AST:ALT ratio &ge;2, an elevated serum bilirubin (&gt;5 <span class=\"nowrap\">mg/dL</span> or 86 <span class=\"nowrap\">micromol/L),</span> and an elevated INR [<a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/3,4,10,11,19\" class=\"abstract_t\">3,4,10,11,19</a>]. The presence of a fever or leukocytosis supports the diagnosis. </p><p>In order to rule out other common causes of acute hepatitis, patients should be tested for the following: </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Anti-hepatitis A IgM</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Hepatitis B surface antigen, anti-hepatitis B core IgM</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Anti-hepatitis C virus (HCV) antibodies, hepatitis C RNA</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Biliary obstruction or Budd-Chiari syndrome using transabdominal ultrasound with Doppler</p><p/><p>In a patient with chronic liver disease (eg, alcoholic cirrhosis or HCV), diagnosing alcoholic hepatitis may be difficult because the signs, symptoms, and laboratory test findings may be similar. In such patients, the diagnosis is made based on the strength of the clinical findings as well as the likelihood of an alternative diagnosis (eg, decompensated cirrhosis). Despite this difficulty, there is increasing interest in clinical trials for the disease, which has generated more rigorous, standardized criteria for establishing a diagnosis of alcoholic hepatitis, which should allow more consistent inclusion and characterization of patients in therapeutic trials [<a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/37,38\" class=\"abstract_t\">37,38</a>]. These include: onset of jaundice within prior eight weeks; ongoing consumption of &gt;40 (female) or 60 (male) g alcohol per day for six months or more, with less than 60 days of abstinence before the onset of jaundice; aspartate aminotransferase &gt;50, aspartate <span class=\"nowrap\">aminotransferase/alanine</span> aminotransferase &gt;1.5-fold, and both values &lt;400 International <span class=\"nowrap\">Units/L;</span> serum bilirubin (total) &gt;3 <span class=\"nowrap\">mg/dL;</span> and liver biopsy confirmation in patients with confounding factors. In addition, stratification should be based on severity as assessed by: Maddrey discriminant function &gt;32, assuming a control prothrombin time of 12 seconds; and model for end stage liver disease (MELD) &gt;20. In addition, the authors have defined common data elements and end points to be assessed in an effort to further standardize clinical trial design for experimental therapies [<a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/37\" class=\"abstract_t\">37</a>]. (See <a href=\"#H234080897\" class=\"local\">'Chronic liver disease'</a> below.)</p><p>In a study of patients with chronically elevated liver biochemical tests, the sensitivity and specificity of clinical findings for diagnosing alcoholic liver disease were 91 and 97 percent, respectively, when liver biopsy was used as the gold standard [<a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/39\" class=\"abstract_t\">39</a>]. However, the sensitivity and specificity of clinical findings for diagnosing the subset of patients with alcoholic hepatitis are unclear. There are no laboratory or radiologic tests currently being used that are specific for alcoholic hepatitis.</p><p>Patients with risk factors for other causes of acute hepatitis (eg, hypotensive episodes, pregnancy, possible <a href=\"topic.htm?path=acetaminophen-paracetamol-drug-information\" class=\"drug drug_general\">acetaminophen</a> overdose, or other drug toxicity) or with a clinical picture that is only partially consistent with alcoholic hepatitis require a more extensive evaluation. In some cases, if the serologic and radiologic evaluations do not provide a diagnosis, a liver biopsy may be required. In addition, some groups recommend a liver biopsy in patients with severe alcoholic hepatitis for whom treatment is being contemplated to confirm the diagnosis [<a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/7\" class=\"abstract_t\">7</a>]. However, it is our practice to obtain a biopsy only when there is doubt about the diagnosis and other co-factors or concurrent causes of liver disease are suspected, or if enrollment in a clinical trial requires an entry biopsy to confirm the diagnosis. Liver biopsies in patients with alcoholic hepatitis are typically performed transvenously because patients often have coagulopathies. (See <a href=\"#H163571291\" class=\"local\">'Differential diagnosis'</a> below and <a href=\"topic.htm?path=approach-to-the-patient-with-abnormal-liver-biochemical-and-function-tests\" class=\"medical medical_review\">&quot;Approach to the patient with abnormal liver biochemical and function tests&quot;</a> and <a href=\"topic.htm?path=transjugular-liver-biopsy\" class=\"medical medical_review\">&quot;Transjugular liver biopsy&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H418822036\"><span class=\"h2\">Pathologic criteria for alcoholic hepatitis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Approximately 10 to 35 percent of patients who abuse alcohol will have changes in liver histology suggestive of alcoholic hepatitis [<a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/40\" class=\"abstract_t\">40</a>]. While many patients with suspected alcoholic hepatitis will not require a liver biopsy, pathologic findings may help with the diagnosis if there is uncertainty [<a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/41\" class=\"abstract_t\">41</a>]. However, the histologic findings are not specific for alcoholic hepatitis and may also be seen in patients with nonalcoholic steatohepatitis. As noted below, a standardized scoring system has been developed in order to stratify severity more accurately based on pathologic appearance [<a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/42\" class=\"abstract_t\">42</a>].</p><p>Histologic findings in liver biopsies from patients with alcoholic hepatitis include (<a href=\"image.htm?imageKey=GAST%2F58504\" class=\"graphic graphic_picture graphicRef58504 \">picture 1</a> and <a href=\"image.htm?imageKey=GAST%2F75188\" class=\"graphic graphic_picture graphicRef75188 \">picture 2</a>) [<a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/43,44\" class=\"abstract_t\">43,44</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Steatosis: Typically micro- or macrovesicular steatosis, but in some cases alcoholic foamy degeneration is seen</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Hepatocellular ballooning with cytoplasmic rarefaction</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Infiltration by neutrophils or lymphocytes</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Mallory-Denk bodies</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Fibrosis with a perivenular, perisinusoidal, and pericellular distribution</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Cholestasis</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Bile duct proliferation</p><p/><p>In early stages, the inflammatory changes affect the perivenular regions (zone 3). However, as the disease progresses, the histologic changes may extend to the portal tracts. The findings may vary among patients with regard to their extent and severity.</p><p>The presence of neutrophils is a hallmark of alcoholic hepatitis and is unusual in chronic viral hepatitis. Their role in pathogenesis is discussed separately. (See <a href=\"topic.htm?path=pathogenesis-of-alcoholic-liver-disease\" class=\"medical medical_review\">&quot;Pathogenesis of alcoholic liver disease&quot;</a>.)</p><p>Mallory-Denk bodies (previously called Mallory bodies or Mallory's hyaline) are eosinophilic accumulations of intracellular protein aggregates within the cytoplasm of hepatocytes (<a href=\"image.htm?imageKey=GAST%2F75188\" class=\"graphic graphic_picture graphicRef75188 \">picture 2</a>). They represent condensations of intracellular &quot;intermediate filaments&quot; or cytokeratins, which are normal components of the hepatocyte cytoskeleton [<a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/45\" class=\"abstract_t\">45</a>]. The mechanisms underlying Mallory-Denk body formation in alcoholic hepatitis are unclear. Furthermore, they are not specific for alcoholic hepatitis and can be seen in nonalcoholic steatohepatitis [<a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/46\" class=\"abstract_t\">46</a>], Indian childhood cirrhosis (thought in part to be due to high copper intake), starvation, after jejunoileal bypass surgery for morbid obesity, or after the use of certain drugs (such as <a href=\"topic.htm?path=amiodarone-drug-information\" class=\"drug drug_general\">amiodarone</a> or perhexiline). (See <a href=\"topic.htm?path=epidemiology-clinical-features-and-diagnosis-of-nonalcoholic-fatty-liver-disease-in-adults\" class=\"medical medical_review\">&quot;Epidemiology, clinical features, and diagnosis of nonalcoholic fatty liver disease in adults&quot;</a>.)</p><p>Mallory-Denk bodies do not appear to have a pathogenic role in the hepatic injury. However, their presence is an important marker of alcohol-induced injury. In a large, multicenter Veterans Administration study, for example, Mallory-Denk bodies were detected in 76 percent of those with alcoholic hepatitis and 95 percent of those who also had cirrhosis [<a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/47\" class=\"abstract_t\">47</a>].</p><p class=\"headingAnchor\" id=\"H232016213\"><span class=\"h2\">Assessing disease severity</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Several models have been proposed to determine the severity of a patient's alcoholic hepatitis. The models are discussed in detail elsewhere. (See <a href=\"topic.htm?path=management-and-prognosis-of-alcoholic-hepatitis#H325299748\" class=\"medical medical_review\">&quot;Management and prognosis of alcoholic hepatitis&quot;, section on 'Determining disease severity'</a>.)</p><p class=\"headingAnchor\" id=\"H163571291\"><span class=\"h1\">DIFFERENTIAL DIAGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>There are numerous causes of acute hepatitis, including viral infection, drug reactions, and ischemia. The primary features that differentiate alcoholic hepatitis from other causes of acute hepatitis include a history of heavy alcohol use and an AST:ALT ratio of &ge;2. An AST:ALT ratio of &ge;2 is rarely seen in other forms of liver disease [<a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/22-24\" class=\"abstract_t\">22-24</a>]. Decompensated cirrhosis should also be considered in patients with underlying chronic liver disease (including alcoholic cirrhosis). (See <a href=\"#H234080897\" class=\"local\">'Chronic liver disease'</a> below.)</p><p class=\"headingAnchor\" id=\"H234081025\"><span class=\"h2\">Acute hepatitis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The differential diagnosis of patients presenting with acute hepatitis is broad and includes other liver diseases such as:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"topic.htm?path=acetaminophen-paracetamol-drug-information\" class=\"drug drug_general\">Acetaminophen</a> toxicity</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Drug-induced liver <span class=\"nowrap\">injury/idiosyncratic</span> drug reactions (including herbal supplements and illicit drugs)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Nonalcoholic steatohepatitis</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Acute viral hepatitis (hepatitis A, hepatitis B, hepatitis C, hepatitis D, hepatitis E, herpes simplex virus, Epstein-Barr virus, cytomegalovirus) </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Ischemic hepatitis</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Budd-Chiari syndrome</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>HELLP (hemolysis, elevated liver enzymes, low platelets) syndrome</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Acute fatty liver of pregnancy</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Wilson disease</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Autoimmune hepatitis</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Alpha-1 antitrypsin deficiency</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Toxin-induced hepatitis (eg, mushroom poisoning, carbon tetrachloride)</p><p/><p>Elevated aminotransferases may also be seen in patients with diseases such as:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Muscle diseases</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Thyroid disease</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Celiac disease</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Adrenal insufficiency</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Anorexia nervosa</p><p/><p>Differentiating among these entities requires a through history to identify risk factors and physical examination to look for signs that may point to a specific cause (eg, Kayser-Fleisher rings in a patient with Wilson disease). The history and physical examination are then followed by laboratory testing. Causes of acute hepatitis other than alcoholic hepatitis are often associated with higher transaminase levels than typically seen with alcoholic hepatitis (eg, viral hepatitis, ischemic hepatitis, drug toxicity or idiosyncratic drug reactions,) and typically have an aspartate aminotransferase to alanine aminotransferase ratio of &lt;2 (and often &lt;1).</p><p>Liver biopsy may be required if the cause for a patient's elevated aminotransferases cannot be determined noninvasively. A histologic scoring system has been developed that may make biopsy more useful in more accurately assessing prognosis [<a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/42\" class=\"abstract_t\">42</a>]. (See <a href=\"topic.htm?path=histologic-scoring-systems-for-chronic-liver-disease#H1366946536\" class=\"medical medical_review\">&quot;Histologic scoring systems for chronic liver disease&quot;, section on 'Alcoholic liver disease and alcoholic hepatitis'</a>.) The approach to the evaluation of a patient with abnormal liver tests is discussed in detail elsewhere (see <a href=\"topic.htm?path=approach-to-the-patient-with-abnormal-liver-biochemical-and-function-tests\" class=\"medical medical_review\">&quot;Approach to the patient with abnormal liver biochemical and function tests&quot;</a> and <a href=\"topic.htm?path=acute-liver-failure-in-adults-etiology-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">&quot;Acute liver failure in adults: Etiology, clinical manifestations, and diagnosis&quot;</a>). </p><p class=\"headingAnchor\" id=\"H234080897\"><span class=\"h2\">Chronic liver disease</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Patients who abuse alcohol may have chronic liver disease due to either alcohol (alcoholic steatosis, hepatitis, or cirrhosis) <span class=\"nowrap\">and/or</span> to nonalcohol-related causes (eg, hepatitis C, nonalcoholic fatty liver disease [NAFLD], metabolic diseases) [<a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/48,49\" class=\"abstract_t\">48,49</a>]. Making a diagnosis in such patients may be complicated because the signs, symptoms, and laboratory test findings may be similar. Viral hepatitis can be excluded with appropriate serum tests, but distinguishing alcoholic liver disease from NAFLD may be more difficult. Distinguishing alcoholic from nonalcoholic liver disease can be aided by the use of a validated model formula that incorporates mean corpuscular volume, body mass index, gender, and the AST to ALT ratio [<a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/50\" class=\"abstract_t\">50</a>]. (See <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-alcoholic-fatty-liver-disease-and-alcoholic-cirrhosis#H11\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of alcoholic fatty liver disease and alcoholic cirrhosis&quot;, section on 'Differentiating alcoholic from nonalcoholic liver disease'</a>.)</p><p>In a patient with chronic liver disease without cirrhosis or who has compensated cirrhosis, we will make a diagnosis of alcoholic hepatitis if the clinical history is consistent with alcoholic hepatitis (eg, recent onset of jaundice, AST and ALT both &lt;500 int. <span class=\"nowrap\">units/L</span> with an AST:ALT ratio &ge;2). We will pursue liver biopsy if there is doubt with regard to the correct diagnosis, if there is concern that the patient may have concurrent liver disease (eg, drug induced or NAFLD), or if the findings will influence management or enrollment in a clinical trial of novel therapies. (See <a href=\"topic.htm?path=management-and-prognosis-of-alcoholic-hepatitis#H234081688\" class=\"medical medical_review\">&quot;Management and prognosis of alcoholic hepatitis&quot;, section on 'Patients with severe alcoholic hepatitis'</a>.) </p><p>In a patient with Child B or C cirrhosis, differentiating alcoholic hepatitis from decompensated cirrhosis is particularly difficult because many of the manifestations are the same (jaundice, ascites, hepatorenal syndrome, hepatic encephalopathy), and alcohol use is a risk factor for hepatic decompensation. However, it is important to recognize, that bouts of acute alcoholic hepatitis may occur in a patient who already has cirrhosis, which confers a higher risk of liver failure compared with those who have alcoholic hepatitis or cirrhosis alone [<a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/51,52\" class=\"abstract_t\">51,52</a>]. In such cases, patients are at high risk for hepatic decompensation (eg, spontaneous bacterial peritonitis, gastrointestinal bleeding) and must be monitored especially closely. Disease-specific therapy (eg, corticosteroids) and more general measures for treating liver failure may be required concurrently. (See <a href=\"#H163571291\" class=\"local\">'Differential diagnosis'</a> above and <a href=\"topic.htm?path=management-and-prognosis-of-alcoholic-hepatitis#H234081688\" class=\"medical medical_review\">&quot;Management and prognosis of alcoholic hepatitis&quot;, section on 'Patients with severe alcoholic hepatitis'</a> and <a href=\"topic.htm?path=cirrhosis-in-adults-overview-of-complications-general-management-and-prognosis#H2\" class=\"medical medical_review\">&quot;Cirrhosis in adults: Overview of complications, general management, and prognosis&quot;, section on 'Major complications'</a>.)</p><p class=\"headingAnchor\" id=\"H4086322148\"><span class=\"h1\">SOCIETY GUIDELINE LINKS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See <a href=\"topic.htm?path=society-guideline-links-alcoholic-liver-disease\" class=\"medical medical_society_guidelines\">&quot;Society guideline links: Alcoholic liver disease&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H418824100\"><span class=\"h1\">SUMMARY AND RECOMMENDATIONS</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Patients with alcoholic hepatitis typically have a history of heavy alcohol use (&gt;100 <span class=\"nowrap\">g/day)</span> for more than 20 years, but heavy drinking may be surreptitious or intermittent, without episodes of obvious intoxication (<a href=\"image.htm?imageKey=PC%2F68118\" class=\"graphic graphic_figure graphicRef68118 \">figure 1</a>). (See <a href=\"#H66806154\" class=\"local\">'History'</a> above.) </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Clinicians should not overlook the long-term need to encourage treatment for alcohol use disorder once the acute episode of alcoholic hepatitis has resolved. (See <a href=\"topic.htm?path=risky-drinking-and-alcohol-use-disorder-epidemiology-pathogenesis-clinical-manifestations-course-assessment-and-diagnosis\" class=\"medical medical_review\">&quot;Risky drinking and alcohol use disorder: Epidemiology, pathogenesis, clinical manifestations, course, assessment, and diagnosis&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The characteristic clinical features of alcoholic hepatitis are jaundice, anorexia, fever, and tender hepatomegaly. Laboratory testing reveals moderately elevated transaminases (typically less than 300 int. <span class=\"nowrap\">unit/mL),</span> with an aspartate aminotransferase (AST) to alanine aminotransferase (ALT) ratio of two or greater. Patients may also present with right <span class=\"nowrap\">upper-quadrant/epigastric</span> pain, hepatic encephalopathy, and signs of malnutrition. (See <a href=\"#H418822022\" class=\"local\">'Clinical manifestations'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Clinical and laboratory features are often adequate for establishing the diagnosis of alcoholic hepatitis in a patient with a long history of heavy alcohol use, provided the patient does not have risk factors for other causes of acute hepatitis and testing for other common causes of hepatitis is negative. If the diagnosis is not certain, then liver biopsy can establish alcohol as the likely etiology with greater certainty. (See <a href=\"#H418822029\" class=\"local\">'Diagnosis'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>There are numerous causes of acute hepatitis, including viral infection, drug reactions, and ischemia. The primary features that differentiate alcoholic hepatitis from other causes of acute hepatitis include a history of heavy alcohol use and an AST:ALT ratio of &ge;2. Decompensated cirrhosis can occur concurrently with acute alcoholic hepatitis and confers a higher risk of liver failure compared with those who have alcoholic hepatitis or cirrhosis alone. (See <a href=\"#H163571291\" class=\"local\">'Differential diagnosis'</a> above.)</p><p/></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/1\" class=\"nounderline abstract_t\">Jinjuvadia R, Liangpunsakul S, Translational Research and Evolving Alcoholic Hepatitis Treatment Consortium. Trends in Alcoholic Hepatitis-related Hospitalizations, Financial Burden, and Mortality in the United States. J Clin Gastroenterol 2015; 49:506.</a></li><li><a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/2\" class=\"nounderline abstract_t\">Fedeli U, Avossa F, Guzzinati S, et al. Trends in mortality from chronic liver disease. Ann Epidemiol 2014; 24:522.</a></li><li><a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/3\" class=\"nounderline abstract_t\">Mendenhall CL, Moritz TE, Roselle GA, et al. A study of oral nutritional support with oxandrolone in malnourished patients with alcoholic hepatitis: results of a Department of Veterans Affairs cooperative study. Hepatology 1993; 17:564.</a></li><li><a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/4\" class=\"nounderline abstract_t\">Naveau S, Giraud V, Borotto E, et al. Excess weight risk factor for alcoholic liver disease. Hepatology 1997; 25:108.</a></li><li><a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/5\" class=\"nounderline abstract_t\">European Association for the Study of Liver. EASL clinical practical guidelines: management of alcoholic liver disease. J Hepatol 2012; 57:399.</a></li><li><a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/6\" class=\"nounderline abstract_t\">Friedmann PD. Clinical practice. Alcohol use in adults. N Engl J Med 2013; 368:365.</a></li><li><a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/7\" class=\"nounderline abstract_t\">Singal AK, Bataller R, Ahn J, et al. ACG Clinical Guideline: Alcoholic Liver Disease. Am J Gastroenterol 2018; 113:175.</a></li><li><a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/8\" class=\"nounderline abstract_t\">Cohen SM, Ahn J. Review article: the diagnosis and management of alcoholic hepatitis. Aliment Pharmacol Ther 2009; 30:3.</a></li><li><a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/9\" class=\"nounderline abstract_t\">Choi G, Runyon BA. Alcoholic hepatitis: a clinician's guide. Clin Liver Dis 2012; 16:371.</a></li><li><a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/10\" class=\"nounderline abstract_t\">Stewart S, Prince M, Bassendine M, et al. A randomized trial of antioxidant therapy alone or with corticosteroids in acute alcoholic hepatitis. J Hepatol 2007; 47:277.</a></li><li><a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/11\" class=\"nounderline abstract_t\">Phillips M, Curtis H, Portmann B, et al. Antioxidants versus corticosteroids in the treatment of severe alcoholic hepatitis--a randomised clinical trial. J Hepatol 2006; 44:784.</a></li><li><a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/12\" class=\"nounderline abstract_t\">Lischner MW, Alexander JF, Galambos JT. Natural history of alcoholic hepatitis. I. The acute disease. Am J Dig Dis 1971; 16:481.</a></li><li><a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/13\" class=\"nounderline abstract_t\">Mendenhall CL. Alcoholic hepatitis. Clin Gastroenterol 1981; 10:417.</a></li><li><a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/14\" class=\"nounderline abstract_t\">Levitsky J, Mailliard ME. Diagnosis and therapy of alcoholic liver disease. Semin Liver Dis 2004; 24:233.</a></li><li><a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/15\" class=\"nounderline abstract_t\">Mathurin P, Lucey MR. Management of alcoholic hepatitis. J Hepatol 2012; 56 Suppl 1:S39.</a></li><li><a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/16\" class=\"nounderline abstract_t\">Baraona E, Leo MA, Borowsky SA, Lieber CS. Alcoholic hepatomegaly: accumulation of protein in the liver. Science 1975; 190:794.</a></li><li><a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/17\" class=\"nounderline abstract_t\">Akriviadis E, Botla R, Briggs W, et al. Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial. Gastroenterology 2000; 119:1637.</a></li><li><a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/18\" class=\"nounderline abstract_t\">Mendenhall CL, Anderson S, Weesner RE, et al. Protein-calorie malnutrition associated with alcoholic hepatitis. Veterans Administration Cooperative Study Group on Alcoholic Hepatitis. Am J Med 1984; 76:211.</a></li><li><a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/19\" class=\"nounderline abstract_t\">Lucey MR, Mathurin P, Morgan TR. Alcoholic hepatitis. N Engl J Med 2009; 360:2758.</a></li><li><a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/20\" class=\"nounderline abstract_t\">Uchida T, Kao H, Quispe-Sjogren M, Peters RL. Alcoholic foamy degeneration--a pattern of acute alcoholic injury of the liver. Gastroenterology 1983; 84:683.</a></li><li><a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/21\" class=\"nounderline abstract_t\">Bosilkovska M, Walder B, Besson M, et al. Analgesics in patients with hepatic impairment: pharmacology and clinical implications. Drugs 2012; 72:1645.</a></li><li><a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/22\" class=\"nounderline abstract_t\">Cohen JA, Kaplan MM. The SGOT/SGPT ratio--an indicator of alcoholic liver disease. Dig Dis Sci 1979; 24:835.</a></li><li><a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/23\" class=\"nounderline abstract_t\">Sorbi D, Boynton J, Lindor KD. The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease. Am J Gastroenterol 1999; 94:1018.</a></li><li><a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/24\" class=\"nounderline abstract_t\">Williams AL, Hoofnagle JH. Ratio of serum aspartate to alanine aminotransferase in chronic hepatitis. Relationship to cirrhosis. Gastroenterology 1988; 95:734.</a></li><li><a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/25\" class=\"nounderline abstract_t\">Diehl AM, Potter J, Boitnott J, et al. Relationship between pyridoxal 5'-phosphate deficiency and aminotransferase levels in alcoholic hepatitis. Gastroenterology 1984; 86:632.</a></li><li><a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/26\" class=\"nounderline abstract_t\">Nguyen-Khac E, Thevenot T, Piquet MA, et al. Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis. N Engl J Med 2011; 365:1781.</a></li><li><a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/27\" class=\"nounderline abstract_t\">Louvet A, Diaz E, Dharancy S, et al. Early switch to pentoxifylline in patients with severe alcoholic hepatitis is inefficient in non-responders to corticosteroids. J Hepatol 2008; 48:465.</a></li><li><a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/28\" class=\"nounderline abstract_t\">Mathurin P, Mendenhall CL, Carithers RL Jr, et al. Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AH. J Hepatol 2002; 36:480.</a></li><li><a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/29\" class=\"nounderline abstract_t\">Mitchell RG, Michael M 3rd, Sandidge D. High mortality among patients with the leukemoid reaction and alcoholic hepatitis. South Med J 1991; 84:281.</a></li><li><a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/30\" class=\"nounderline abstract_t\">Carlson J, Eriksson S. Alpha 1-antitrypsin and other acute phase reactants in liver disease. Acta Med Scand 1980; 207:79.</a></li><li><a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/31\" class=\"nounderline abstract_t\">Mihas AA. Serum alpha 1-antitrypsin levels in alcoholic hepatitis. Digestion 1978; 17:275.</a></li><li><a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/32\" class=\"nounderline abstract_t\">Tran TN, Eubanks SK, Schaffer KJ, et al. Secretion of ferritin by rat hepatoma cells and its regulation by inflammatory cytokines and iron. Blood 1997; 90:4979.</a></li><li><a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/33\" class=\"nounderline abstract_t\">Sumino Y, Kravetz D, Kanel GC, et al. Ultrasonographic diagnosis of acute alcoholic hepatitis 'pseudoparallel channel sign' of intrahepatic artery dilatation. Gastroenterology 1993; 105:1477.</a></li><li><a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/34\" class=\"nounderline abstract_t\">Han SH, Rice S, Cohen SM, et al. Duplex Doppler ultrasound of the hepatic artery in patients with acute alcoholic hepatitis. J Clin Gastroenterol 2002; 34:573.</a></li><li><a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/35\" class=\"nounderline abstract_t\">Janssens F, de Suray N, Piessevaux H, et al. Can transient elastography replace liver histology for determination of advanced fibrosis in alcoholic patients: a real-life study. J Clin Gastroenterol 2010; 44:575.</a></li><li><a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/36\" class=\"nounderline abstract_t\">Trabut JB, Th&eacute;pot V, Nalpas B, et al. Rapid decline of liver stiffness following alcohol withdrawal in heavy drinkers. Alcohol Clin Exp Res 2012; 36:1407.</a></li><li><a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/37\" class=\"nounderline abstract_t\">Crabb DW, Bataller R, Chalasani NP, et al. Standard Definitions and Common Data Elements for Clinical Trials in Patients With Alcoholic Hepatitis: Recommendation From the NIAAA Alcoholic Hepatitis Consortia. Gastroenterology 2016; 150:785.</a></li><li><a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/38\" class=\"nounderline abstract_t\">Gholam PM. Prognosis and Prognostic Scoring Models for Alcoholic Liver Disease and Acute Alcoholic Hepatitis. Clin Liver Dis 2016; 20:491.</a></li><li><a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/39\" class=\"nounderline abstract_t\">Van Ness MM, Diehl AM. Is liver biopsy useful in the evaluation of patients with chronically elevated liver enzymes? Ann Intern Med 1989; 111:473.</a></li><li><a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/40\" class=\"nounderline abstract_t\">Adachi M, Brenner DA. Clinical syndromes of alcoholic liver disease. Dig Dis 2005; 23:255.</a></li><li><a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/41\" class=\"nounderline abstract_t\">Alcoholic liver disease: morphological manifestations. Review by an international group. Lancet 1981; 1:707.</a></li><li><a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/42\" class=\"nounderline abstract_t\">Altamirano J, Miquel R, Katoonizadeh A, et al. A histologic scoring system for prognosis of patients with alcoholic hepatitis. Gastroenterology 2014; 146:1231.</a></li><li><a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/43\" class=\"nounderline abstract_t\">Ishak KG, Zimmerman HJ, Ray MB. Alcoholic liver disease: pathologic, pathogenetic and clinical aspects. Alcohol Clin Exp Res 1991; 15:45.</a></li><li><a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/44\" class=\"nounderline abstract_t\">Lefkowitch JH. Morphology of alcoholic liver disease. Clin Liver Dis 2005; 9:37.</a></li><li><a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/45\" class=\"nounderline abstract_t\">Denk H, Lackinger E. Cytoskeleton in liver diseases. Semin Liver Dis 1986; 6:199.</a></li><li><a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/46\" class=\"nounderline abstract_t\">Bacon BR, Farahvash MJ, Janney CG, Neuschwander-Tetri BA. Nonalcoholic steatohepatitis: an expanded clinical entity. Gastroenterology 1994; 107:1103.</a></li><li><a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/47\" class=\"nounderline abstract_t\">French SW, Nash J, Shitabata P, et al. Pathology of alcoholic liver disease. VA Cooperative Study Group 119. Semin Liver Dis 1993; 13:154.</a></li><li><a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/48\" class=\"nounderline abstract_t\">Levin DM, Baker AL, Riddell RH, et al. Nonalcoholic liver disease. Overlooked causes of liver injury in patients with heavy alcohol consumption. Am J Med 1979; 66:429.</a></li><li><a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/49\" class=\"nounderline abstract_t\">Mendenhall CL, Moritz T, Chedid A, et al. Relevance of anti-HCV reactivity in patients with alcoholic hepatitis. VA cooperative Study Group #275. Gastroenterol Jpn 1993; 28 Suppl 5:95.</a></li><li><a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/50\" class=\"nounderline abstract_t\">Dunn W, Angulo P, Sanderson S, et al. Utility of a new model to diagnose an alcohol basis for steatohepatitis. Gastroenterology 2006; 131:1057.</a></li><li><a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/51\" class=\"nounderline abstract_t\">Chedid A, Mendenhall CL, Gartside P, et al. Prognostic factors in alcoholic liver disease. VA Cooperative Study Group. Am J Gastroenterol 1991; 86:210.</a></li><li><a href=\"https://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis/abstract/52\" class=\"nounderline abstract_t\">Morgan MY. The prognosis and outcome of alcoholic liver disease. Alcohol Alcohol Suppl 1994; 2:335.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 86934 Version 17.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H418824100\"><span>SUMMARY &amp; RECOMMENDATIONS</span></a></li><li><a href=\"#H418822015\" id=\"outline-link-H418822015\">INTRODUCTION</a></li><li><a href=\"#H66806154\" id=\"outline-link-H66806154\">HISTORY</a></li><li><a href=\"#H418822022\" id=\"outline-link-H418822022\">CLINICAL MANIFESTATIONS</a><ul><li><a href=\"#H428430251\" id=\"outline-link-H428430251\">Signs and symptoms</a></li><li><a href=\"#H66805637\" id=\"outline-link-H66805637\">Physical examination</a></li><li><a href=\"#H418826776\" id=\"outline-link-H418826776\">Laboratory tests</a><ul><li><a href=\"#H706893162\" id=\"outline-link-H706893162\">- Liver test abnormalities</a></li><li><a href=\"#H706893171\" id=\"outline-link-H706893171\">- Coagulation abnormalities</a></li><li><a href=\"#H706893178\" id=\"outline-link-H706893178\">- Hematologic abnormalities</a></li><li><a href=\"#H706893185\" id=\"outline-link-H706893185\">- Other laboratory test abnormalities</a></li></ul></li><li><a href=\"#H62755805\" id=\"outline-link-H62755805\">Imaging tests</a></li></ul></li><li><a href=\"#H418822029\" id=\"outline-link-H418822029\">DIAGNOSIS</a><ul><li><a href=\"#H234080095\" id=\"outline-link-H234080095\">Diagnostic approach</a></li><li><a href=\"#H418822036\" id=\"outline-link-H418822036\">Pathologic criteria for alcoholic hepatitis</a></li><li><a href=\"#H232016213\" id=\"outline-link-H232016213\">Assessing disease severity</a></li></ul></li><li><a href=\"#H163571291\" id=\"outline-link-H163571291\">DIFFERENTIAL DIAGNOSIS</a><ul><li><a href=\"#H234081025\" id=\"outline-link-H234081025\">Acute hepatitis</a></li><li><a href=\"#H234080897\" id=\"outline-link-H234080897\">Chronic liver disease</a></li></ul></li><li><a href=\"#H4086322148\" id=\"outline-link-H4086322148\">SOCIETY GUIDELINE LINKS</a></li><li><a href=\"#H418824100\" id=\"outline-link-H418824100\">SUMMARY AND RECOMMENDATIONS</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"GAST/86934|FIG\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"FIGURES\">FIGURES</a></div><ul><li><a href=\"image.htm?imageKey=PC/68118\" class=\"graphic graphic_figure\">- Definition standard drink</a></li></ul></li><li><div id=\"GAST/86934|PIC\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"PICTURES\">PICTURES</a></div><ul><li><a href=\"image.htm?imageKey=GAST/58504\" class=\"graphic graphic_picture\">- Alcoholic hepatitis Light</a></li><li><a href=\"image.htm?imageKey=GAST/75188\" class=\"graphic graphic_picture\">- Mallory body alcohol hepatitis</a></li></ul></li><li><div id=\"GAST/86934|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=PC/54106\" class=\"graphic graphic_table\">- CAGE questionnaire</a></li><li><a href=\"image.htm?imageKey=PC/74262\" class=\"graphic graphic_table\">- AUDIT</a></li><li><a href=\"image.htm?imageKey=GAST/62922\" class=\"graphic graphic_table\">- Stages hepatic encephalopathy</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=acute-liver-failure-in-adults-etiology-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">Acute liver failure in adults: Etiology, clinical manifestations, and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=acute-phase-reactants\" class=\"medical medical_review\">Acute phase reactants</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=approach-to-the-patient-with-abnormal-liver-biochemical-and-function-tests\" class=\"medical medical_review\">Approach to the patient with abnormal liver biochemical and function tests</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=cirrhosis-in-adults-etiologies-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">Cirrhosis in adults: Etiologies, clinical manifestations, and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=cirrhosis-in-adults-overview-of-complications-general-management-and-prognosis\" class=\"medical medical_review\">Cirrhosis in adults: Overview of complications, general management, and prognosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-alcoholic-fatty-liver-disease-and-alcoholic-cirrhosis\" class=\"medical medical_review\">Clinical manifestations and diagnosis of alcoholic fatty liver disease and alcoholic cirrhosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=epidemiology-clinical-features-and-diagnosis-of-nonalcoholic-fatty-liver-disease-in-adults\" class=\"medical medical_review\">Epidemiology, clinical features, and diagnosis of nonalcoholic fatty liver disease in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=hematologic-complications-of-alcohol-use\" class=\"medical medical_review\">Hematologic complications of alcohol use</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=hepatorenal-syndrome\" class=\"medical medical_review\">Hepatorenal syndrome</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=histologic-scoring-systems-for-chronic-liver-disease\" class=\"medical medical_review\">Histologic scoring systems for chronic liver disease</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=management-and-prognosis-of-alcoholic-hepatitis\" class=\"medical medical_review\">Management and prognosis of alcoholic hepatitis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=noninvasive-assessment-of-hepatic-fibrosis-ultrasound-based-elastography\" class=\"medical medical_review\">Noninvasive assessment of hepatic fibrosis: Ultrasound-based elastography</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=nutritional-assessment-in-chronic-liver-disease\" class=\"medical medical_review\">Nutritional assessment in chronic liver disease</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=pathogenesis-of-alcoholic-liver-disease\" class=\"medical medical_review\">Pathogenesis of alcoholic liver disease</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=prognosis-and-management-of-alcoholic-fatty-liver-disease-and-alcoholic-cirrhosis\" class=\"medical medical_review\">Prognosis and management of alcoholic fatty liver disease and alcoholic cirrhosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=risky-drinking-and-alcohol-use-disorder-epidemiology-pathogenesis-clinical-manifestations-course-assessment-and-diagnosis\" class=\"medical medical_review\">Risky drinking and alcohol use disorder: Epidemiology, pathogenesis, clinical manifestations, course, assessment, and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=screening-for-unhealthy-use-of-alcohol-and-other-drugs-in-primary-care\" class=\"medical medical_review\">Screening for unhealthy use of alcohol and other drugs in primary care</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=society-guideline-links-alcoholic-liver-disease\" class=\"medical medical_society_guidelines\">Society guideline links: Alcoholic liver disease</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=transjugular-liver-biopsy\" class=\"medical medical_review\">Transjugular liver biopsy</a></li></ul></div></div>","javascript":null}